Nephros (NEPH) Enterprise Value (2016 - 2025)
Nephros (NEPH) has 16 years of Enterprise Value data on record, last reported at -$5.2 million in Q3 2025.
- For Q3 2025, Enterprise Value fell 110.46% year-over-year to -$5.2 million; the TTM value through Sep 2025 reached -$5.2 million, down 110.46%, while the annual FY2024 figure was -$3.8 million, 12.7% up from the prior year.
- Enterprise Value reached -$5.2 million in Q3 2025 per NEPH's latest filing, down from -$5.1 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$345000.0 in Q4 2022 and bottomed at -$5.2 million in Q2 2021.
- Average Enterprise Value over 5 years is -$3.5 million, with a median of -$3.9 million recorded in 2021.
- Peak YoY movement for Enterprise Value: surged 91.2% in 2022, then crashed 1148.41% in 2023.
- A 5-year view of Enterprise Value shows it stood at -$3.9 million in 2021, then soared by 91.2% to -$345000.0 in 2022, then plummeted by 1148.41% to -$4.3 million in 2023, then increased by 12.7% to -$3.8 million in 2024, then plummeted by 37.53% to -$5.2 million in 2025.
- Per Business Quant database, its latest 3 readings for Enterprise Value were -$5.2 million in Q3 2025, -$5.1 million in Q2 2025, and -$4.1 million in Q1 2025.